Day: March 4, 2025

Bear Creek Mining Announces Strategic Review, Appointment of Christian Milau as Strategic Advisor

Written by Customer Service on March 4, 2025. Posted in Public Companies.

VANCOUVER, British Columbia, March 04, 2025 (GLOBE NEWSWIRE) — Bear Creek Mining Corporation (TSXV: BCM) (OTCQX:BCEKF) (BVL: BCM) (“Bear Creek” or the “Company”) announces that its Board of Directors (the “Board”) has initiated a comprehensive and thorough strategic review process (the “Strategic Review”) to explore and evaluate, on an expeditious basis, the strategic and financial options available to the Company with the ultimate view of enhancing value. The Board has also established a special committee of independent directors (the “Special Committee”) to manage the process, with a goal to complete the Strategic Review on an expeditious basis. Mr. Milau will advise the Special Committee and Board as the Company carries out the Strategic Review. Strategic Review The strategic and financial options that may be considered under...

Bear Creek Mining Announces Brokered Private Placement, Appointment of Peter C. Mitchell and Ian Grundy as Directors, Debt Amendments and Credit Extension

Written by Customer Service on March 4, 2025. Posted in Public Companies.

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, March 04, 2025 (GLOBE NEWSWIRE) — Bear Creek Mining Corporation (TSXV: BCM) (BVL: BCM) (“Bear Creek” or the “Company”) announces that it has entered into an agreement with BMO Capital Markets to act as sole bookrunner, on behalf of a syndicate of underwriters (collectively, the “Underwriters”), on a bought deal basis, for a private placement of 64,445,000 common shares of the Company (each, a “Share”), at a price of C$0.225 per Share (the “Offering Price”) to raise aggregate gross proceeds of approximately C$14.5 million (the “Offering”). Pursuant to the Offering, the Company has granted the Underwriters an option to purchase an additional 9,666,750 Shares pursuant to the Offering for additional gross...

Beamr Issues Annual CEO Letter to Shareholders: Highlighting 2024 Achievements and 2025 Strategy – Capitalizing on Market Validation

Written by Customer Service on March 4, 2025. Posted in Public Companies.

In 2025, Beamr plans to leverage the strong market validation it has gained in numerous meetings with prospective customers across key target markets, as well as participation in major events with industry leaders Herzliya, Israel, March 04, 2025 (GLOBE NEWSWIRE) — Beamr Imaging Ltd. (NASDAQ: BMR), a leader in video optimization technology and solutions, today issued a Letter to Shareholders from Sharon Carmel, Chief Executive Officer. Dear Shareholders: As we look toward a promising and exciting year ahead, I am proud to reflect on Beamr’s achievements throughout 2024, including our financial results and strong cash position for 2024, our recent accomplishments so far in Q1 2025, and look forward to our plans for Q2 2025. We believe that during 2025, Beamr will capitalize on the significant validation it has created in 2024 and...

APAM Announces Jason Gottlieb as Chief Executive Officer and Eric Colson as Executive Chair

Written by Customer Service on March 4, 2025. Posted in Public Companies.

MILWAUKEE, March 04, 2025 (GLOBE NEWSWIRE) — Artisan Partners Asset Management Inc. (NYSE: APAM, the “Company”) announced today the appointment of Jason Gottlieb, current President of the Company, to succeed Eric Colson as Chief Executive Officer, and the appointment of Mr. Colson as Executive Chair of the Company, each effective following the Company’s 2025 annual meeting of stockholders on June 4, 2025. At that time, it is expected that Mr. Gottlieb will be elected to the Company’s Board of Directors, and Mr. Colson will become Chair of the Board, assuming the role from Stephanie DiMarco who will transition to Lead Independent Director. Mr. Gottlieb joined Artisan Partners in October 2016 as a Managing Director of Investment Operations. He was promoted to Chief Operating Officer of Investments and Executive Vice President in...

Neuronetics Reports Fourth Quarter and Full Year 2024 Financial and Operating Results

Written by Customer Service on March 4, 2025. Posted in Earnings Releases And Operating Results.

MALVERN, Pa., March 04, 2025 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”) a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the lives of patients whenever and wherever they need help, with the leading neurohealth therapies in the world, today announced its financial and operating results for the fourth quarter and full year of 2024. Fourth Quarter 2024 HighlightsAcquired Greenbrook TMS on December 9, 2024 Received an incremental $10 million in funding from Perceptive Advisors Fourth quarter 2024 revenue of $22.5 million, a 11% increase as compared to the fourth quarter 2023 U.S. NeuroStar Advanced Therapy System revenue of $3.8 million in the quarter U.S. treatment session revenue of $12.9 million No Greenbrook...

Instil Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Written by Customer Service on March 4, 2025. Posted in Earnings Releases And Operating Results.

Clinical data for AXN-2510/IMM2510 monotherapy in relapsed/refractory NSCLC in China by ImmuneOnco, as well as additional safety data in other solid tumors, anticipated in 1H 2025 Enrollment of 1L NSCLC patients in trial of AXN-2510/IMM2510 and chemotherapy by ImmuneOnco in China anticipated to begin in Q2 2025 with initial clinical data by ImmuneOnco expected in 2H 2025 Initiation of U.S. clinical study of AXN-2510/IMM2510 in combination with chemotherapy in 1L NSCLC anticipated before the end of 2025, assuming receipt of necessary regulatory approvals DALLAS, March 04, 2025 (GLOBE NEWSWIRE) — Instil Bio, Inc. (“Instil”) (Nasdaq: TIL), a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies, today reported its fourth quarter and full year 2024 financial results and provided a corporate update. Recent...

Aclaris Therapeutics to Participate in Two March Healthcare Conferences

Written by Customer Service on March 4, 2025. Posted in Public Companies.

WAYNE, Pa., March 04, 2025 (GLOBE NEWSWIRE) — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that the Company will participate in two upcoming healthcare conferences in March.On Tuesday March 11, 2025, at 3:00 PM EDT, Aclaris’ Chief Executive Officer Dr. Neal Walker and other members of Aclaris’ senior leadership team will participate in a fireside chat during the Leerink Partners Global Healthcare Conference in Miami, Florida.On Thursday March 27, 2025, at 9:00 AM EDT, Dr. Walker and other members of Aclaris’ senior leadership team will participate in a virtual fireside chat during the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual ConferenceA live and archived...

Turmalina Metals Name Change to King Copper Discovery Corp.

Written by Customer Service on March 4, 2025. Posted in Public Companies.

VANCOUVER, British Columbia, March 04, 2025 (GLOBE NEWSWIRE) — Turmalina Metals Corp. (“Turmalina”, or the “Company”; TBX-TSXV, TBXXF-OTCQB, 3RI-FSE) is pleased to provide an update on the recently announced corporate name change, from “Turmalina Metals Corp.” to “King Copper Discovery Corp.” and a symbol change on the TSXV from TBX to KCP, which is effective March 11, 2025 (the “Name Change“). The new CUSIP number for the Company’s common shares will be 494726102, and the new ISIN number will be CA4947261026. The share capital of the Company will remain unchanged. The updating of various presentation materials, which is in progress, will reflect the Company’s focus on the Colquemayo copper-gold-silver project, which is located in the Moquegua department, near the border with the Arequipa department in Southern Peru. The...

Conavi Medical Highly Encouraged by New U.S. Intracoronary Guidelines

Written by Customer Service on March 4, 2025. Posted in Public Companies.

– IVUS and OCT cited as playing essential and complementary roles, validating Novasight’s unique hybrid imaging capability – Guidelines constitute strong recommendations based on the highest level of evidence – Clinical data show intracoronary imaging leads to lower risk of target vessel failure (including cardiac death) in coronary procedures – Company anticipates similar changes to other guidelines covering coronary procedures TORONTO, March 04, 2025 (GLOBE NEWSWIRE) — Conavi Medical Corp. (TSXV: CNVI; OTC: CNVIF) (“Conavi Medical” or the “Company”), a commercial stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures, responded today to new intracoronary imaging guidelines by the American College of Cardiology, American...

Solaris Signs Letter of Intent with Influential Indigenous Organization in Morona Santiago, Ecuador

Written by Customer Service on March 4, 2025. Posted in Public Companies.

HIGHLIGHTS:Solaris has formed an Inter-Institutional working group with the Arutam Shuar People (“PSHA”), ratified through the signing of a Letter of Intent (“LOI”)The Company has formed an Inter-Institutional working group with the PSHA, together with our host communities of Warints and Yawi and the Ecuadorian State The PSHA and its Governing Council ratified this process through the signing of a LOI aimed at advancing dialogue in order to reach a future cooperation agreementExpanded Infill resource drilling programme at Warintza has been concludedAn updated MRE, expected to be published mid-2025, will encompass over 80,000m of drilling The updated MRE will be included into the Pre-Feasibility Study, due to be released in Q3 2025QUITO, Ecuador, March 04, 2025 (GLOBE NEWSWIRE) — Solaris Resources Inc. (“Solaris”...

Day: March 4, 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals